Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
PLOS One; https://doi.org/10.1371/journal.pone.0203659
Sirtuin 3 attenuates amyloid-β induced neuronal hypometabolism
AgING; doi: 10.18632/aging.101592.
Inhibition of Phosphodiesterase-4 Reverses Aβ-Induced Memory Impairment by Regulation of HPA Axis Related cAMP Signaling.
Frontiers in Aging Neuroscience; doi: 10.3389/fnagi.2018.00204.
Cerebrospinal fluid from Alzheimer patients affects cell-mediated nerve growth factor production and cell survival in vitro.
Experimental Cell Research; DOI: 10.1016/j.yexcr.2018.08.007.
CLPFFD–PEG functionalized NIR-absorbing hollow gold nanospheres and gold nanorods inhibit β-amyloid aggregation.
Journal of Materials Chemistry B; DOI:10.1039/C8TB00655E.
Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy.
Biochim Biophys Acta Mol Basis Dis; https://doi.org/10.1016/j.bbadis.2018.03.023.
Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity
Journal of Neuroinflammation; https://doi.org/10.1186/s12974-017-1027-y.
Lipid transporter Spns2 promotes microglia pro‐inflammatory activation in response to amyloid‐beta peptide
GLIA; https://doi.org/10.1002/glia.23558.
Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide
Science Direct; https://doi.org/10.1016/j.mcn.2018.03.015.
L‐proline and betaine inhibit extracellular enzymes mediated abeta 1‐42 aggregation, oxidative stress, and toxicity.
PeptideScience; https://doi.org/10.1002/pep2.24093.